HEOR Services Market
Report ID: SQMIG35D2476
Report ID: SQMIG35D2476
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35D2476 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
180
|Figures:
79
Global Heor Services Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.36 Billion in 2025 to USD 5.91 Billion by 2033, growing at a CAGR of 12.19% during the forecast period (2026-2033).
The HEOR Services market facilitates stakeholders’ decision making by generating evidence of clinical effectiveness, cost-effectiveness, and patient reported outcomes to demonstrate value, which is driving increased demand as healthcare budgets tighten and prescription drug prices increase, pushing manufacturers to measure the value of their product(s) compared to the cost of the product. The HEOR Services market has advanced significantly from its early roots in pharmacoeconomic studies conducted primarily for academic reasons in the early 1990s to fully integrated HEOR programs that include both real-world evidence and predictive analytics through advanced analytics and large population-based studies/registries and clinical studies. An example of this is the various oncology value frameworks that have developed in the past few years, which assist with formulary access and reimbursement negotiations across the world.
Ultimately, one of the reasons for accelerated growth of HEOR services worldwide is the rapid increase in available sources of real-world data used for longitudinal outcome tracking and personalized value assessments, thus increasing demand for advanced analytics and data linkage. Since the volume of data contained in repositories such as Electronic Health Records (EHR), claims databases, and patient registries has increased significantly, sponsors are using HEOR firms to conduct studies comparing the clinical effectiveness of their product versus the competitor(s) and from these studies, to develop models for predicting post-launch product safety and budget impact, which the sponsor can use to gain a better price for their product(s) and access to the market. For example, a diabetes therapy manufacturer used claims-based outcomes to demonstrate reduced hospitalizations, which caused payers to approve broader coverage and justified outcomes-based contracting, highlighting clear business and patient care opportunities.
How is AI Improving Real-world Evidence Generation in the HEOR Services Market?
AI is changing the way we collect real-world data for Health Economics and Outcomes Research (HEOR), making fragmented data useable as evidence more quickly and consistently. For example, Natural Language Processing (NLP) enables the extraction of clinical meaning from clinical notes, Machine Learning (ML) identifies patient cohort(s), and Generative AI supports the study design and hypothesis testing processes. The current market is transitioning from manual curation to AI-enabled pipelines that provide shorter timelines and increased reproducibility in the analysis of data.
In addition to providing improved evidence, the payer and manufacturer communities continue to request richer outcome information as well as improved operational efficiencies. Examples of both improved evidence generation and operational efficiencies include AI-enabled oncology registries and Electronic Health Record (EHR) based programs that utilize AI to identify treatment patterns or safety signals for HEOR teams.
Ontada will release a new product called ON.Journey (May 2026), which will use oncology-specific artificial intelligence (AI) and natural language processing (NLP) to extract information from both structured and unstructured clinical records to provide HEOR teams with richer, more timely, and less manual real-world evidence. This will facilitate faster decision-making and improve the operational efficiency of evidence generation workflow processes.
Market snapshot - (2026-2033)
Global Market Size
USD 2.1 Billion
Largest Segment
Market Access Services
Fastest Growth
Data Analytics & Modeling Services
Growth Rate
12.19% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global heor services market is segmented by by service type, by service provider, by deployment type, by application, by end user, by study type and region. Based on by service type, the market is segmented into Health Economics Services, Outcomes Research Services, Market Access Services, Data Analytics & Modeling Services and Others. Based on by service provider, the market is segmented into Contract Research Organizations, Consulting Firms, Healthcare Analytics Companies and Others. Based on by deployment type, the market is segmented into In-house Services and Outsourced Services. Based on by application, the market is segmented into Oncology, Cardiovascular Disorders, Neurology, Infectious Diseases, Rare Diseases, Metabolic Disorders and Others. Based on by end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Healthcare Providers, Government & Payers and Others. Based on by study type, the market is segmented into Retrospective Studies, Prospective Studies and Modeling-based Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As market access services are driven by the need for evidence linking clinical outcomes with value by payers and reimbursement agencies, and because market access teams have developed knowledge of how to produce dossiers, pricing and payer engagement plans, the segment will continue to be dominant. Furthermore, the understanding of how to support product launches and develop market access strategies will position market access teams as critical to the planning of product launches while establishing priorities in the HEOR services market and attracting ongoing funding from sponsors.
Data analytics and modeling services are evolving to be the fastest-growing segment of the HEOR services market due to the increased ability to aggregate real-world data, machine learning and simulation technology. The additional ability to develop predictive insights will improve decision making throughout development and reimbursement, creating new commercial opportunities.
Contract Research Organizations (CROs) are rapidly becoming a dominant force in the HEOR Services Market as sponsors are increasingly turning to CROs for their ability to conduct complex HEOR studies by leveraging the CROs’ operational scale, regulatory expertise and established investigator networks to execute retrospective and prospective studies. Provided with integrated project management, access to data relationships, and experience with delivering payer facing evidence generation, CROs can quickly operationalize HEOR strategies, which makes them either the sole providers or preferred partners for development programs.
Meanwhile, Healthcare Analytics Companies (HACs) are experiencing unprecedented growth acceleration as they utilize advanced analytics platforms, cloud technologies, and artificial intelligence to generate new analytical methods to analyze/interpret outcomes and cost data more deeply. The highly specialized analytical tools of HACs enable the acceleration of the development of models and generation of real world evidence for all stakeholders, thereby driving the expansion of HEOR adoption and the creation of new commercialization channels through the expansion of service offerings and strategic partnerships.
To get detailed segments analysis, Request a Free Sample Report
The dominance of North America in the global HEOR services market stems from a unique blend of its advanced payer system, mature assessment framework, and a concentrated cluster of biopharma and contract research organizations that are committed to generating evidence. The advanced methodological skill set, combined with an extensive infrastructure of real world data, allows for comprehensive economic modeling and analysis of health outcomes that helps inform pricing, market access, and reimbursement strategies. In addition, there is a culture of collaboration among academia, industry, and policymakers that promotes the development of rigorous comparative effectiveness research and health economic modeling in complicated therapeutic areas. Adult highly developed regulatory and payer expectations result in continued demand for the production of high quality HEOR deliverables through a highly developed network of specialized consulting firms and an expert workforce representing multiple disciplines. Moreover, establishing long-term relationships with health systems, along with access to payer-level data, ensures that strategic HEOR positions are fully supported.
The United States HEOR Services Market is influenced by national health data, a mature payer landscape, and dynamic pharmaceutical research that requires rigorous evaluation of their economic impact. The primary areas of focus for HEOR in the U.S. include conducting cost-effectiveness analyses, long-term outcome modeling, and utilizing real-world evidence to fulfill national criteria for reimbursement. The enhancement of the quality of HEOR methodology is further achieved through collaboration among industry, academia, and government. Additionally, regional consultancies provide custom HEOR services that meet and exceed the requirements of the domestic regulatory framework with respect to addressing complex clinical pathways.
The Canadian HEOR Services Market is influenced by provincial payer systems, a strong emphasis on cost-effectiveness as a priority area, and collaborative health technology assessments. Locally, the demand for real-world evidence, budget impact studies, and modeling that align with provincial and national reimbursement criteria is very high. The strong capacity for conducting research within Canada's post-secondary institutions, and the growing relationships between the pharmaceutical industry and provincial health authorities, also facilitate the completion of value assessments. The Canadian HEOR Services Marketplace provides a conducive environment for the development of custom HEOR services that address the variability of payer systems in Canada and provide the necessary information to support policy decisions.
Rapid expansion of the HEOR services market in Europe reflects aligned priorities among payers, health technology assessment bodies, and industry for rigorous value demonstration and budget impact planning. Increasing emphasis on comparative effectiveness and real world evidence collection across national agencies has elevated demand for sophisticated economic models and patient level analyses. A dense network of specialized consultancies, academic centres, and regional data initiatives supports methodological innovation and local adaptation of global evidence. Cross border collaboration and harmonization efforts encourage standardized approaches while allowing country specific tailoring, positioning Europe as a major growth area for HEOR expertise and integrated market access solutions. Heightened payer scrutiny of value propositions and the emergence of cross stakeholder dialogues have increased the complexity of market access, driving sponsors to invest in bespoke HEOR strategies. Emphasis on patient centered outcomes and inclusion of quality of life measures further broadens methodological requirements.
HEOR Services Market in Germany is driven by rigorous health technology assessment processes and strong expectations for comparative effectiveness. Demand focuses on robust clinical and economic evidence tailored to stringent national assessment criteria, with emphasis on healthcare cost implications. A solid network of specialized consultancies and academic centres supports complex modelling. Close engagement with decision makers and structured assessment pathways reinforces Germany position as a leading market for HEOR deliverables.
HEOR Services Market in the United Kingdom benefits from evolving payer models, active life science policy initiatives, and strong consultancy ecosystems that drive adoption of advanced evidence strategies. Increased emphasis on real world evidence, dialogue with assessment bodies, and flexible reimbursement mechanisms stimulates demand for modelling and outcome research. Collaborative ties between industry, academic centres, and public agencies accelerate methodological development and support HEOR solutions tailored to market access pathways.
HEOR Services Market in France is emerging through expanding acceptance of economic evidence by national agencies and a growing appetite for real world evidence to inform pricing and reimbursement discussions. Local demand emphasizes budget impact analyses, quality of life measures, and contextualized value assessments that address national decision criteria. Partnerships between industry, research centres, and health authorities enhance methodological capacity and encourage sophisticated HEOR submissions aligned with regional access needs.
Asia Pacific is strengthening its role in the HEOR services market through strategic investments in health data infrastructure, growing academic capacity, and increasing collaboration between industry and national health authorities. Expansion of national claims and electronic health record resources enables region specific real world evidence generation and locally relevant economic modelling. Rising regulatory interest in value based assessments and payer demand for contextually appropriate evidence have driven adoption of HEOR methodologies adapted to diverse healthcare systems. Local consultancies and regional centres of excellence are maturing, supporting cross border research, methodological innovation, and tailored market access strategies that reflect varied reimbursement environments across the region. Growing public private partnerships and investment in clinical registries support longitudinal outcomes research, while targeted training programs expand methodological talent pools. Emphasis on technology enabled evidence generation and regional collaboration increases capacity to serve both domestic and multinational sponsors with nuanced HEOR offerings.
HEOR Services Market in Japan is underpinned by national health data, a mature payer environment, and strong pharmaceutical research that demands rigorous economic evaluation. Priority areas include cost effectiveness analyses, long term outcome modelling, and integration of real world evidence to meet national reimbursement criteria. Collaboration between industry, academia, and government fosters methodological rigor. Local consultancies offer tailored HEOR services that effectively address domestic regulatory expectations and complex clinical pathways.
HEOR Services Market in South Korea is strengthened by centralized national insurance frameworks, expanding health data resources, and a vibrant biotech research sector seeking robust value evidence. Demand focuses on economic modelling, budget impact assessments, and real world studies aligned to national reimbursement processes. Strong ties between industry, academic centres, and HTA organisations enhance methodological capabilities. Local providers offer integrated HEOR solutions that support domestic and regional market access strategies.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Demand For Real World Evidence
Advances In Health Data Accessibility
Limited Standardization Of Data
Regulatory And Reimbursement Uncertainty
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape in global HEOR services is consolidating as traditional CROs and consultancies use targeted acquisitions, partnerships, and AI investments to secure payer and HTA evidence advantages; examples include acquisitive moves by Fishawack and Genesis Research and a recent strategic buy by Nexus Health, while vendors deploy AI-enabled RWE platforms and clean room partnerships to differentiate service depth and speed.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, rising demand for real world evidence is a key driver of HEOR services growth, while limited standardization of data serves as a major restraint. The market is dominated by North America and the Market Access Services segment leads service uptake as payers demand evidence for reimbursement. A second driver is advances in health data accessibility, including richer EHRs and claims databases that enable longitudinal analyses and AI driven modeling. Together these forces push HEOR vendors to expand analytics, AI and payer-facing deliverables, but data fragmentation will temper investments and slow some cross border scaling and commercialization.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.1 Billion |
| Market size value in 2033 | USD 5.91 Billion |
| Growth Rate | 12.19% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the HEOR Services Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the HEOR Services Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the HEOR Services Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the HEOR Services Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Heor Services Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.36 Billion in 2025 to USD 5.91 Billion by 2033, growing at a CAGR of 12.19% during the forecast period (2026-2033).
The competitive landscape in global HEOR services is consolidating as traditional CROs and consultancies use targeted acquisitions, partnerships, and AI investments to secure payer and HTA evidence advantages; examples include acquisitive moves by Fishawack and Genesis Research and a recent strategic buy by Nexus Health, while vendors deploy AI-enabled RWE platforms and clean room partnerships to differentiate service depth and speed. 'IQVIA Holdings Inc.', 'Parexel International Corporation', 'Syneos Health Inc.', 'ICON plc', 'EVERSANA', 'Certara Inc.', 'Optum Inc.', 'Analysis Group Inc.', 'RTI Health Solutions', 'Clarivate Plc', 'Pharmerit International', 'Precision AQ', 'Trinity Life Sciences', 'Avalere Health LLC', 'ZS Associates Inc.', 'Kx Advisors LLC', 'Putnam Associates Inc.', 'McKesson Corporation', 'Cytel Inc.', 'Oracle Life Sciences'
This demand compels healthcare stakeholders to seek comprehensive HEOR services to generate actionable insights across patient populations, treatment pathways and long term outcomes. Payers and providers increasingly require comparative effectiveness and value demonstration to inform coverage and clinical decision making, driving the need for specialized modelling, data synthesis and interpretation. As manufacturers aim to demonstrate product differentiation and value to diverse stakeholders, investment in HEOR capabilities grows, expanding service uptake and prompting providers to broaden methodological offerings and consultative engagements.
Real World Evidence Integration: Health economics and outcomes research increasingly incorporates diverse real world evidence sources to generate actionable insights throughout product lifecycles. Payers and manufacturers demand integrated observational, claims, and patient-reported data to inform value narratives and pricing strategies. HEOR teams expand methodologies to synthesize heterogeneous datasets, support adaptive decision making, and demonstrate long-term outcomes in routine practice. Cross-functional collaborations with data scientists, clinicians, and market access specialists accelerate evidence generation, enabling timely value communication and continuous refinement of health economic models. effectively.
Why does North America Dominate the Global HEOR Services Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
